investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

ENANTA PHARMACEUTI
(29251M106)

Funds Reporting Holdings of ENANTA PHARMACEUTI according to 13F filings
Firm Name Shares Held / Principal Amount Market Value Option Report Period Effectiveness Date
Farallon Capital Management LLC 960,000 $81,005k Jun 30, 2019 Aug 14, 2019
First Manhattan Co 617,771 $52,127k Jun 30, 2019 Aug 16, 2019
Renaissance Technologies LLC 550,300 $46,434k Jun 30, 2019 Aug 12, 2019
Acadian Asset Management LLC 405,269 $34,196k Jun 30, 2019 Aug 8, 2019
Armistice Capital LLC 380,000 $32,064k Jun 30, 2019 Aug 14, 2019
Granahan Investment Management Inc 143,799 $12,134k Jun 30, 2019 Aug 14, 2019
Stonepine Capital Management LLC 65,484 $5,526k Jun 30, 2019 Aug 13, 2019
QS Investors LLC 44,840 $3,784k Jun 30, 2019 Aug 14, 2019
Dupont Capital Management Corp 13,477 $1,137k Jun 30, 2019 Jul 30, 2019
Navellier & Associates Inc 9,667 $816k Jun 30, 2019 Jul 17, 2019
Yorktown Management and Research Co Inc 6,034 $509k Jun 30, 2019 Aug 2, 2019
Granite Point Capital Management LP 5,000 $422k Jun 30, 2019 Jul 29, 2019
Pacer Advisors Inc 3,936 $332k Jun 30, 2019 Aug 12, 2019
Boston Family Office LLC 2,750 $232k Jun 30, 2019 Jul 30, 2019
OFI Advisors LLC 2,941 $106k Sep 30, 2015 Nov 16, 2015
Point72 Asset Management LP 400 $34k Jun 30, 2019 Aug 14, 2019

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.